Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancer

  • Naoyuki Nogami
  • , Takaaki Tokito
  • , Yoshitaka Zenke
  • , Miyako Satouchi
  • , Takashi Seto
  • , Hideo Saka
  • , Junko Ohtani
  • , Shirong Han
  • , Kazuo Noguchi
  • , Makoto Nishio

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancer'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science